Article
A substantial proportion of patients over age 65 years with newly diagnosed prostate cancer are not being treated according to existing guidelines for imaging in this setting.
Investigational ProVee System impresses in phase 3 trial in BPH
Pearls & Perspectives: Martin Kathrins, MD, on MED3000 and learning from failed trials
CVAC 2.0 demonstrates efficacy for clearing stones less than 2 cm
Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
Nogapendekin alfa inbakicept shows high CR, avoidance of cystectomy in NMIBC
Most men in EMBARK trial recover T levels following treatment suspension